Research Article
Serum MicroRNA Profiling and Bioinformatics of Patients with Spleen-Deficiency Syndrome
Table 2
KEGG pathways from 11 candidate serum miRNAs of SDS patients.
| Term | Term ID | Targets in the term | miRNAs in the term | value |
| Insulin signaling pathway | hsa04910 | 4 | 8 | 0.0090 | ErbB signaling pathway | hsa04012 | 3 | 7 | 0.0150 | Chemokine signaling pathway | hsa04062 | 4 | 7 | 0.0240 | Endocytosis | hsa04144 | 4 | 6 | 0.0286 | Calcium signaling pathway | hsa04020 | 4 | 5 | 0.0198 | Carbohydrate digestion and absorption | hsa04973 | 2 | 5 | 0.0270 | Ubiquitin mediated proteolysis | hsa04120 | 3 | 5 | 0.0421 | Bacterial invasion of epithelial cells | hsa05100 | 4 | 4 | 0.0009 | FcγR-mediated phagocytosis | hsa04666 | 3 | 4 | 0.0181 | Arginine and proline metabolism | hsa00330 | 2 | 4 | 0.0400 | Galactose metabolism | hsa00052 | 2 | 3 | 0.0108 | Amino sugar and nucleotide sugar metabolism | hsa00520 | 2 | 3 | 0.0315 | Starch and sucrose metabolism | hsa00500 | 2 | 3 | 0.0387 | Pathogenic Escherichia coli infection | hsa05130 | 3 | 2 | 0.0047 | Valine, leucine, and isoleucine degradation | hsa00280 | 2 | 2 | 0.0281 | Type II diabetes mellitus | hsa04930 | 2 | 2 | 0.0315 | Shigellosis | hsa05131 | 2 | 2 | 0.0489 | Fatty acid metabolism | hsa00071 | 3 | 1 | 0.0023 |
|
|